Peer-reviewed veterinary case report
Protein-losing kidney disease in cats - signs and survival
By Sugar, Noam et al.·Published in Journal of veterinary internal medicine·2024·Department of Small Animal Internal Medicine·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study.
- Species:
- cat
Plain-English summary
A 3-year-old male cat was brought to the vet showing signs of lethargy, swelling in the body (edema), and weight loss. The diagnosis was protein-losing nephropathy (PLN), a type of kidney disease that can be treated with specific medications. Cats that received immunosuppressive and antiproteinuric treatments had better chances of survival, and about one-third of the cats showed improvement in their condition. While the prognosis for PLN is generally cautious, those that achieved remission had a significantly better outcome.
People also search for: cat kidney disease symptoms · cat edema treatment · protein-losing nephropathy in cats · cat weight loss causes · cat lethargy and swelling
Abstract
BACKGROUND: Primary glomerular disease resulting in protein-losing nephropathy (PLN) is an uncommon cause of chronic kidney disease in cats, yet is important to recognize because it warrants specific treatment that impacts outcome. HYPOTHESIS/OBJECTIVE: Characterize clinicopathologic findings, prognostic indicators, and short- (≤30 days) and long-term survival of cats with PLN. ANIMALS: Thirty-seven cats with naturally occurring PLN. METHODS: Medical records of cats with PLN admitted to a veterinary teaching hospital were retrospectively reviewed. RESULTS: Median age was 3 years (range, 1.5-11.5 years) and 17/37 (46%) were males. Short-term survival was 57%. The estimated median survival time of all cats was 424 days (95% confidence interval [CI], 0-1098 days). Common clinical signs included lethargy (57%), edema (46%) and weight loss (35%). Edema was more common in short-term survivors compared with nonsurvivors (odds ratio [OR], 0.21; 95% CI, 0.05-0.86-20.4; P = .04). Serum creatinine concentration at presentation was negatively associated with long-term survival (OR, 1.3; 95% CI, 1.03-1.52; P = .01). Administration of immunosuppressive and antiproteinuric medications was more common among short-term survivors compared with nonsurvivors (18/20 [90%] vs 9/16 [56%]; OR, 7.0; 95% CI, 1.2-40.8; P = .05 and 17/20 [85%] vs 7/16 [44%]; OR, 7.3; 95% CI, 1.5-35.2; P = .01, respectively). Partial or complete remission was documented in 11/31 (36%) cats and was associated with both short (OR, 3.3; 95% CI, 1.7-6.5; P < .001) and long-term survival (P = .003). CONCLUSION AND CLINICAL IMPORTANCE: Cats with PLN have a guarded prognosis, but achieving remission improves outcome. Cats presented with edema rather than azotemia are more likely to respond to treatment.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/39481914/